Clinical Trial (Interventional)

Results 26 - 50 of 403
Public Title Project Description Modified
A Phase 3b, Multicenter, Open-Label Study to Evaluate the Long-Term Safety and Efficacy of Subcutane . . . Study H9B-MC-BCDX (BCDX) is an open-label extension (OLE) study that assesses the longterm safety an . . . 01 Dec 2015 03:48:40
A Multicenter, Paired-eye Comparison, Dose-escalation, Single Dose, 24-Month Study of Safety and Eff . . . Bimatoprost Preservative-Free (PF) Intracameral (IC) Drug Delivery System (DDS) (sustained-release b . . . 21 Sep 2017 09:12:11
Study of the Safety and Efficacy of Once-daily Bimatoprost Preservative-free This study is being conducted to establish the potential role of bimatoprost 0.03% PF in the managem . . . 14 Sep 2016 01:03:18
A phase 3, multi-center, randomized, double-blind, placebo-controlled, 52-week study to evaluate the . . . HGS1006-C1115 evaluating the efficacy and safety of belimumab administered subcutaneously (SC) in pa . . . 14 Sep 2016 01:07:49
A multicenter, double-blind, double-dummy, randomized, positive-controlled study comparing the effic . . . SP0993 is a Phase 3, multicenter, double-blind, double-dummy, randomized, positive-controlled study . . . 13 Feb 2017 03:08:51
A 24-week phase III randomized, double-blind, parallel group study to evaluate the efficacy and safe . . . This randomised, double-blind, multi-national, active-controlled, parallel group trial will evaluate . . . 01 Sep 2015 04:37:39
A Phase 3B Study to Evaluate the Potential of Aleglitazar to Reduce Cardiovascular Risk in Patients . . . This study is a randomized, double-blind, placebo-controlled, parallel group, multicenter study in p . . . 09 Sep 2015 09:06:19
A Phase III placebo-controlled, double-blind, randomized trial to evaluate the efficacy and safety o . . . TMC207-TiDP13-C210 is a randomized, double-blind, placebo-controlled, 2-arm, multicenter, Phase III . . . 20 Dec 2013 04:56:34
A Long-term, Safety, Tolerability, and Efficacy Study of Retigabine Immediate-release (IR) in Asian . . . This is a multicentre, long-term, open-label extension (OLE) study to follow Study RTG114855 (the p . . . 17 Sep 2013 09:31:40
Ceftazidime-Avibactam for the Treatment of Infections Due to Ceftazidime Resistant Pathogens This is a Phase III, prospective, open-label, randomized, multicenter, study to evaluate the efficac . . . 22 Aug 2013 03:51:37
A multicenter open-label study to evaluate the safety and efficacy of PEG-Intron™ versus PEGASYS℠. . . This is a randomized, active-controlled, parallel-group, multi-site, open label study of PEG-Intron . . . 11 Dec 2013 03:58:17
Phase 3 study on Schizoprenia an Extension of Study ALK9072-003 This study involves the patients with stable schizophrenia 12 Feb 2016 12:54:38
DB2114634: A 24-week randomised, double-blind and placebo-controlled study to evaluate the efficacy . . . To evaluate the efficacy and safety of GSK573719/GW642444 Inhalation Powder at 125/25mcg and 62.5/25 . . . 06 Jun 2014 03:04:57
Oral zinc gluconate as treatment for recalcitrant cutaneous warts: A randomized, double-blind, plac . . . Up to one-third of common warts can remain recalcitrant, an occurrence that has been attributed to i . . . 28 May 2013 03:34:20
A Study to Assess the Long Term Effect, Safety and Metabolism of a Solifenacin Liquid Suspension in . . . The purpose of this study is to investigate a medicine for the treatment of symptoms and complicatio . . . 30 May 2016 10:52:49
A 12-week treatment, randomized, blinded, double-dummy, parallel-group study to assess the efficacy, . . . The purpose of this study is to allow a blinded comparison of the spirometric and symptomatic effica . . . 03 Jan 2014 02:16:43
A 26-week treatment, randomised, double-blind, placebo-controlled, parallel group study to assess th . . . The purpose of this study was to provide efficacy and safety data for the 50 ÎĽg o.d. dose of NVA237 . . . 03 Jan 2014 02:14:15
A 14 week, randomized, double-blind, multi-center, parallel group, active controlled study to evalua . . . The purpose of this study is to access the efficacy and safety of LCZ696 compared to olmesartan in e . . . 11 Nov 2013 09:09:19
A randomized, 8-week, double-blind, parallel-group, active-controlled, multi-center study to evaluat . . . The purpose of this study is to assess whether LCZ696 when used in combination with amlodipine will . . . 11 Nov 2013 09:10:28
Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk (FOURI . . . The primary hypothesis is that additional LDL-C lowering with AMG 145 when used in addition to other . . . 08 Apr 2016 09:34:32
An Efficacy Study Of GSK Biologicals' Quadrivalent Influenza Vaccine GSK2321138A (FLU D-QIV) When Ad . . . The purpose of this study is to evaluate the efficacy, immunogenicity and safety of GSK Biologicals' . . . 21 Nov 2017 03:52:27
EUCLID This study will be conducted in approximately 950 investigational centres in approximately 25 countr . . . 22 Aug 2013 07:57:56
LABA Safety Study Based on initial feasibility, this study is planned to be conducted at approximately 700 centers in . . . 22 Aug 2013 08:00:08
Rivaroxaban for the prevention of major cardiovascular events in coronary or peripheral artery disea . . . The primary purpose of this study is to evaluate whether treatment with rivaroxaban and aspirin or r . . . 12 Jun 2013 09:49:57
A prospective, multicenter, comparative, open label, randomized phase III study to assess immunogeni . . . "LGLS has some licensed vaccines for Diphtheria, Tetanus, Pertusis, HB, Hib and some experiences for . . . 09 Sep 2014 10:09:32

Copyright © One Window Project 2018. All rights reserved.